News NHS to axe 18-week ops waiting target Cancer care and mental health to take priority, says health chief.
News Charities unite to oppose NICE rare disease rules MPs to discuss controversial plan in special debate.
Views & Analysis Pharma could take NHS England to court over new delaying tac... New cost-capping and delaying measures will further restrict access to new medicines say pharma and patient groups.
News Pharma attacks plan to ration new drugs in England Plans to ration and delay use of novel drugs in England have been condemned by the pharma industry and a health charity.
News Digital heart scan can save NHS millions HeartFlow could save NHS England a minimum of around £9.1 million by 2022.
News Alexion lambasts NICE over rare disease ruling Watchdog accused of ignoring stakeholder consensus and call for negotiations
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
